Vivli Executive Director, Rebecca Li, spoke at the Duke-Margolis Center for Health Policy event entitled “Data Capture to Measure, Track, and Improve Antibiotic Use” on March 2nd. She took part in the panel discussion for ‘Policy Approaches to Improve Data Capture for Antibiotic Use’ which discussed the need for the expansion of programs to capture antimicrobial resistance surveillance data, and the barriers stakeholders encounter in gathering evidence for novel antibiotics.
Vivli Executive Director Rebecca Li and Antimicrobial Development Consultant Patricia Bradford recently authored a Viewpoint article entitled “Access to industry antimicrobial resistance (AMR) susceptibility surveillance data” in the GARDP REVIVE newsletter. This paper aims to raise awareness of the availability of high-quality AMR susceptibility data collected from surveillance programs by the pharmaceutical industry. These data are freely available and can be requested through the AMR Register by researchers wishing to advance the fight against antimicrobial resistance.
Vivli’s Executive Director, Dr. Rebecca Li, spoke at The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Public Meeting on September 13th for the Innovation Spotlight, on the topic “AMR Register – An Innovative platform for sharing industry surveillance data”. Dr. Li spoke alongside other companies with innovations in antimicrobial resistance. View Dr. Li’s slides here.
This meeting of PACCARB aimed to “identify key issues and critical policy gaps through a series of facilitated discussions examining a hypothetical large-scale disease outbreak scenario based on historic examples and estimates of future AMR outbreaks.”
Further information about the meeting can be found here.